These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 27747937)

  • 1. Potassium-sodium citrate prevents the development of renal microcalculi into symptomatic stones in calcium stone-forming patients.
    Unno R; Taguchi K; Okada A; Ando R; Hamamoto S; Kubota Y; Zuo L; Tozawa K; Kohri K; Yasui T
    Int J Urol; 2017 Jan; 24(1):75-81. PubMed ID: 27747937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Re: Potassium-sodium citrate prevents the development of renal microcalculi into symptomatic stones in calcium stone-forming patients.
    Chen Z
    Int J Urol; 2017 Apr; 24(4):334. PubMed ID: 28070904
    [No Abstract]   [Full Text] [Related]  

  • 3. Response to Re: Potassium-sodium citrate prevents the development of renal microcalculi into symptomatic stones in calcium stone-forming patients.
    Unno R; Taguchi K; Okada A; Ando R; Hamamoto S; Kubota Y; Zuo L; Tozawa K; Kohri K; Yasui T
    Int J Urol; 2017 Apr; 24(4):334-335. PubMed ID: 28208228
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of Potassium Citrate on Calcium Phosphate Stones in a Model of Hypercalciuria.
    Krieger NS; Asplin JR; Frick KK; Granja I; Culbertson CD; Ng A; Grynpas MD; Bushinsky DA
    J Am Soc Nephrol; 2015 Dec; 26(12):3001-8. PubMed ID: 25855777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of sodium bicarbonate upon urinary citrate excretion in calcium stone formers.
    Pinheiro VB; Baxmann AC; Tiselius HG; Heilberg IP
    Urology; 2013 Jul; 82(1):33-7. PubMed ID: 23602798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissolution of radiolucent renal stones by oral alkalinization with potassium citrate/potassium bicarbonate.
    Trinchieri A; Esposito N; Castelnuovo C
    Arch Ital Urol Androl; 2009 Sep; 81(3):188-91. PubMed ID: 19911683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in urinary parameters after oral administration of potassium-sodium citrate and magnesium oxide to prevent urolithiasis.
    Kato Y; Yamaguchi S; Yachiku S; Nakazono S; Hori J; Wada N; Hou K
    Urology; 2004 Jan; 63(1):7-11; discussion 11-2. PubMed ID: 14751336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
    Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL
    J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potassium citrate decreases urine calcium excretion in patients with hypocitraturic calcium oxalate nephrolithiasis.
    Song Y; Hernandez N; Shoag J; Goldfarb DS; Eisner BH
    Urolithiasis; 2016 Apr; 44(2):145-8. PubMed ID: 26582172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment Response in Patients with Stones, and Low Urinary pH and Hypocitraturia Stratified by Body Mass Index.
    Astroza GM; Neisius A; Tsivian M; Preminger GM; Lipkin ME
    J Urol; 2016 Mar; 195(3):653-7. PubMed ID: 26393903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potassium citrate vs. hydrochlorothiazide to reduce urinary calcium excretion in calcium oxalate stone patients with hypercalciuria: a prospective randomized study.
    Solak V; Gökce Mİ; Yaman Ö
    Int Urol Nephrol; 2021 Sep; 53(9):1791-1796. PubMed ID: 33904027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiological and physiochemical correction and prevention of calcium stone formation by potassium citrate therapy.
    Pak CY; Sakhaee K; Fuller CJ
    Trans Assoc Am Physicians; 1983; 96():294-305. PubMed ID: 6679957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of potassium citrate therapy on stone recurrence and residual fragments after shockwave lithotripsy in lower caliceal calcium oxalate urolithiasis: a randomized controlled trial.
    Soygür T; Akbay A; Küpeli S
    J Endourol; 2002 Apr; 16(3):149-52. PubMed ID: 12028622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alkaline citrate reduces stone recurrence and regrowth after shockwave lithotripsy and percutaneous nephrolithotomy.
    Lojanapiwat B; Tanthanuch M; Pripathanont C; Ratchanon S; Srinualnad S; Taweemonkongsap T; Kanyok S; Lammongkolkul S
    Int Braz J Urol; 2011; 37(5):611-6. PubMed ID: 22099273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agglomeration inhibition reflected stone-forming activity during long-term potassium citrate therapy in calcium stone formers.
    Fuselier HA; Moore K; Lindberg J; Husserl FE; Cole FE; Kok DJ; Whitehead D; Galliano DJ; Erwin DT
    Urology; 1998 Dec; 52(6):988-94. PubMed ID: 9836542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal tubular cell damage and oxidative stress in renal stone patients and the effect of potassium citrate treatment.
    Tungsanga K; Sriboonlue P; Futrakul P; Yachantha C; Tosukhowong P
    Urol Res; 2005 Feb; 33(1):65-9. PubMed ID: 15565439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Citrate and renal stones].
    del Valle EE; Spivacow FR; Negri AL
    Medicina (B Aires); 2013; 73(4):363-8. PubMed ID: 23924538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is calcium oxalate nucleation in postprandial urine of males with idiopathic recurrent calcium urolithiasis related to calcium phosphate nucleation and the intensity of stone formation? Studies allowing insight into a possible role of urinary free citrate and protein.
    Schwille PO; Schmiedl A; Manoharan M
    Clin Chem Lab Med; 2004 Mar; 42(3):283-93. PubMed ID: 15080561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of spinal bone loss by potassium citrate in cases of calcium urolithiasis.
    Pak CY; Peterson RD; Poindexter J
    J Urol; 2002 Jul; 168(1):31-4. PubMed ID: 12050486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.